- Home
- QSI vs CRMD Comparison
QSI vs CRMD Comparison
Compare QSI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QSI | CRMD |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | 82 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 561.8M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | QSI | CRMD |
|---|---|---|
| Price | $0.96 | $7.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $1.50 | ★ $15.29 |
| AVG Volume (30 Days) | ★ 3.8M | 1.5M |
| Earning Date | 01-01-0001 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 67.03 |
| EPS | N/A | ★ 1.97 |
| Revenue | N/A | ★ $43,472,170.00 |
| Revenue This Year | N/A | $627.64 |
| Revenue Next Year | $159.68 | N/A |
| P/E Ratio | ★ N/A | $3.75 |
| Revenue Growth | N/A | ★ 66363.08 |
| 52 Week Low | $0.89 | $5.60 |
| 52 Week High | $3.10 | $17.43 |
Technical Indicators
Market Signals| Indicator | QSI | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 39.68 |
| Support Level | $0.92 | $6.55 |
| Resistance Level | $1.33 | $8.53 |
| Average True Range (ATR) | 0.07 | 0.26 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 30.56 | 24.74 |
Price Performance
Historical ComparisonAbout QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.